Abstract
There is an immediate need for a noninvasive approach to detect β cell destruction during the initial stages of type I diabetes and late stages of type II diabetes in order to permit early preventative and interventional treatment strategies. The appearance of circulating biomarkers has been highly useful in diagnosing specific organ damage and early detection of some types of cancer. Hence, for nearly two decades, there have been efforts to identify analogous prognosticating factors in diabetes. To date, studies have identified several β cell-selective proteins which have recently been validated as biomarkers for detection of acute islet insulin cell death in vivo: glutamic acid decarboxylase 65 (GAD65), doublecortin (DCX), and protein phosphatase inhibitor 1 (PPP1R1A). More recently, the PCR detection of circulating genomic DNA originating from the β cell by its methylation fingerprint, as well as circulating β cell-specific microRNA, has offered more sensitive means to discern in vivo islet damage. This chapter surveys the current state of β cell biomarkers for real-time detection of cell death in vivo. While preclinical data suggests that we still have a long way to go, the successful translation of the biomarker approach to humans will revolutionize the way in which diabetes is treated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akirav EM, Lebastchi J, Galvan EM, Henegariu O, Akirav M, Ablamunits V, Lizardi PM, Herold KC (2011) Detection of β cell death in diabetes using differentially methylated circulating DNA. Proc Natl Acad Sci U S A 108:19018–19023
Babuin L, Jaffe AS (2005) Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173:1191–1202
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R, Sultmann H (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128:608–616
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Chessler SD, Lernmark A (2000) Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other non-neural tissues. J Biol Chem 275:5188–5192
Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–S107
Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L (2005) Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 21:1–14
Delovitch TL, Singh B (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727–738
Dirkx R Jr, Thomas A, Li L, Lernmark A, Sherwin RS, De Camilli P, Solimena M (1995) Targeting of the 67-kDa isoform of glutamic acid decarboxylase to intracellular organelles is mediated by its interaction with the NH2-terminal region of the 65-kDa isoform of glutamic acid decarboxylase. J Biol Chem 270:2241–2246
Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E (2008) miR-375 targets 3’-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells. Diabetes 57:2708–2717
Emamaullee JA, Shapiro AM (2006) Interventional strategies to prevent β-cell apoptosis in islet transplantation. Diabetes 55:1907–1914
Erener S, Mojibian M, Fox JK, Denroche HC, Kieffer TJ (2013) Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology 154:603–608
Fernandez-Valverde SL, Taft RJ, Mattick JS (2011) MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 60:1825–1831
Gleeson JG, Lin PT, Flanagan LA, Walsh CA (1999) Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 23:257–271
Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD (2001) Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 61:900–902
Hao W, Daniels T, Pipeleers DG, Smismans A, Reijonen H, Nepom GT, Lernmark A (1999) Radioimmunoassay for glutamic acid decarboxylase-65. Diabetes Technol Ther 1:13–20
Hinke SA (2007) Finding GAD: early detection of β-cell injury. Endocrinology 148:4568–4571
Hinke SA (2011) Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes. Drug Dev Res 72:788–804
Husseiny MI, Kuroda A, Kaye AN, Nair I, Kandeel F, Ferreri K (2012) Development of a quantitative methylation-specific polymerase chain reaction method for monitoring β cell death in type 1 diabetes. PLoS One 7:e47942
Jiang L, Brackeva B, Ling Z, Kramer G, Aerts JM, Schuit F, Keymeulen B, Pipeleers D, Gorus F, Martens GA (2013a) Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivo. Diabetes 62:2683–2688
Jiang L, Brackeva B, Stange G, Verhaeghen K, Costa O, Couillard-Despres S, Rotheneichner P, Aigner L, Van Schravendijk C, Pipeleers D et al (2013b) LC-MS/MS identification of doublecortin as abundant β cell-selective protein discharged by damaged β cells in vitro. J Proteomics 80:268–280
Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H, Peveling-Oberhag J, Biondi RM, Zeuzem S, Kronenberger B et al (2013) Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One 8:e75184
Kredo-Russo S, Mandelbaum AD, Ness A, Alon I, Lennox KA, Behlke MA, Hornstein E (2012) Pancreas-enriched miRNA refines endocrine cell differentiation. Development 139:3021–3031
Kuroda A, Rauch TA, Todorov I, Ku HT, Al-Abdullah IH, Kandeel F, Mullen Y, Pfeifer GP, Ferreri K (2009) Insulin gene expression is regulated by DNA methylation. PLoS One 4:e6953
Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401–1414
Lebastchi J, Herold KC (2012) Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007708
Lebastchi J, Deng S, Lebastchi AH, Beshar I, Gitelman S, Willi S, Gottlieb P, Akirav EM, Bluestone JA, Herold KC (2013) Immune therapy and β-cell death in type 1 diabetes. Diabetes 62:1676–1680
Lilja L, Meister B, Berggren PO, Bark C (2005) DARPP-32 and inhibitor-1 are expressed in pancreatic β-cells. Biochem Biophys Res Commun 329:673–677
Makarov DV, Loeb S, Getzenberg RH, Partin AW (2009) Biomarkers for prostate cancer. Annu Rev Med 60:139–151
Mally MI, Cirulli V, Otonkoski T, Soto G, Hayek A (1996) Ontogeny and tissue distribution of human GAD expression. Diabetes 45:496–501
Martens GA, Jiang L, Verhaeghen K, Connolly JB, Geromanos SG, Stange G, Van Oudenhove L, Devreese B, Hellemans KH, Ling Z et al (2010) Protein markers for insulin-producing β cells with higher glucose sensitivity. PLoS One 5:e14214
Martens GA, Jiang L, Hellemans KH, Stange G, Heimberg H, Nielsen FC, Sand O, Van Helden J, Van Lommel L, Schuit F et al (2011) Clusters of conserved β cell marker genes for assessment of β cell phenotype. PLoS One 6:e24134
Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, Nir T, Lennox KA, Behlke MA, Dor Y et al (2011) miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J 30:835–845
Miranda TB, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213:384–390
Muller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, Marth C, Widschwendter M (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63:7641–7645
Neutzsky-Wulff AV, Andreassen KV, Hjuler ST, Feigh M, Bay-Jensen AC, Zheng Q, Henriksen K, Karsdal MA (2012) Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist. J Transl Med 10:214
Nicolaou P, Rodriguez P, Ren X, Zhou X, Qian J, Sadayappan S, Mitton B, Pathak A, Robbins J, Hajjar RJ et al (2009) Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circ Res 104:1012–1020
Oliver CJ, Shenolikar S (1998) Physiologic importance of protein phosphatase inhibitors. Front Biosci 3:D961–D972
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544
Piemonti L, Guidotti LG, Battaglia M (2010) Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes. Adv Exp Med Biol 654:725–747
Pipeleers D, Hoorens A, Marichal-Pipeleers M, Van de Casteele M, Bouwens L, Ling Z (2001) Role of pancreatic β-cells in the process of β-cell death. Diabetes 50(Suppl 1):S52–S57
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226–230
Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, Zavolan M, Stoffel M (2009) miR-375 maintains normal pancreatic α- and β-cell mass. Proc Natl Acad Sci U S A 106:5813–5818
Prentki M, Nolan CJ (2006) Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802–1812
Rui M, Hampe CS, Wang C, Ling Z, Gorus FK, Lernmark A, Pipeleers DG, De Pauw PE (2007) Species and epitope specificity of two 65 kDa glutamate decarboxylase time-resolved fluorometric immunoassays. J Immunol Methods 319:133–143
Schlosser M, Hahmann J, Ziegler B, Augstein P, Ziegler M (1997) Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65. J Immunoassay 18:289–307
Schomaker S, Warner R, Bock J, Johnson K, Potter D, Van Winkle J, Aubrecht J (2013) Assessment of emerging biomarkers of liver injury in human subjects. Toxicol Sci 132:276–283
Shapiro AM, Hao EG, Lakey JR, Yakimets WJ, Churchill TA, Mitlianga PG, Papadopoulos GK, Elliott JF, Rajotte RV, Kneteman NM (2001) Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 71:1709–1718
Smismans A, Ling Z, Pipeleers D (1996) Damaged rat β cells discharge glutamate decarboxylase in the extracellular medium. Biochem Biophys Res Commun 228:293–297
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Vander Mierde D, Scheuner D, Quintens R, Patel R, Song B, Tsukamoto K, Beullens M, Kaufman RJ, Bollen M, Schuit FC (2007) Glucose activates a protein phosphatase-1-mediated signaling pathway to enhance overall translation in pancreatic β-cells. Endocrinology 148:609–617
Wai DH, Schaefer KL, Schramm A, Korsching E, Van Valen F, Ozaki T, Boecker W, Schweigerer L, Dockhorn-Dworniczak B, Poremba C (2002) Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 20:441–451
Waldrop MA, Suckow AT, Hall TR, Hampe CS, Marcovina SM, Chessler SD (2006) A highly sensitive immunoassay resistant to autoantibody interference for detection of the diabetes-associated autoantigen glutamic acid decarboxylase 65 in blood and other biological samples. Diabetes Technol Ther 8:207–218
Waldrop MA, Suckow AT, Marcovina SM, Chessler SD (2007) Release of glutamate decarboxylase-65 into the circulation by injured pancreatic islet β-cells. Endocrinology 148:4572–4578
Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, Goke B, Lamerz R, Kolligs FT (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12:7347–7352
Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104:17040–17045
Winter WE, Schatz DA (2011) Autoimmune markers in diabetes. Clin Chem 57:168–175
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Hinke, S.A. (2015). In Vivo Biomarkers for Detection of β Cell Death. In: Islam, M. (eds) Islets of Langerhans. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6686-0_35
Download citation
DOI: https://doi.org/10.1007/978-94-007-6686-0_35
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6685-3
Online ISBN: 978-94-007-6686-0
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences